QA/QC

MHRA consultation on application of AQbD principles enters last month

16 August 2019 | By European Pharmaceutical Review

An MHRA consultation is due to end on 31 August, with public comments on AQbD principles closing soon.

Cannabinoids in pharma series: cannabinoids on the market today

15 August 2019 | By Victoria Rees (European Pharmaceutical Review)

This series investigates the growing interest from the pharmaceutical industry in cannabinoids. In this first piece, we hear from industry experts about the current situation of the ingredient on the pharmaceutical market.

Letter highlights issues with US drug returns verification requirements

14 August 2019 | By Victoria Rees (European Pharmaceutical Review)

An open letter has underscored the challenges of return failure in the US drug supply chain, especially after the introduction of the Drug Supply Chain Security Act in November.

Application note: Cell-Based Therapies – Be on the Safe Side

8 August 2019 | By Sartorius

Get QC Results for Advanced Therapy Medicinal Products (ATMPs) Before Treatment.

Whitepaper: USP <797> Revisions and Impact

7 August 2019 | By Particle Measuring Systems

The United States Pharmacopeia (USP) is a scientific non-profit organization that sets standards used worldwide for the identity, quality, purity and strength of medicines, food ingredients and dietary supplements.

Accelerate food, pharmaceutical and particle analysis with Raman imaging

7 August 2019 | By WITec GmbH

This webinar will describe how Raman microscopy can help solve some of the most vital and challenging questions that researchers face in 3D imaging and microparticle analyses of food, pharmaceuticals and microplastics, along with providing measurement examples from each field.

Whitepaper: Recent advances in pharmaceutical regulations for viable environmental monitoring

6 August 2019 | By Particle Measuring Systems

Regulations provide specifications for the selection of an effective air monitoring strategy, both directly and indirectly.

Perigord

SGS Life Sciences

Climate change: how pharma will profit from a warming planet

5 August 2019 | By Victoria Rees (European Pharmaceutical Review)

Rising temperatures will likely accelerate the spread of vector-borne diseases, resulting in an increased demand for vaccines. European Pharmaceutical Review investigates a Morgan Stanley report on the pharmaceutical beneficiaries of climate change.

Tecan Synergence™ offers comprehensive approach to OEM system development

2 August 2019 | By Tecan

Tecan Partnering has consolidated its extensive OEM system development services for life sciences and IVD instruments to create Tecan Synergence™.

Surge in negative verifications of saleable returns could cost pharma industry billions

31 July 2019 | By Riya Cao

The pharmaceutical industry is set to face some major changes in the near future, to improve the quality of returned drugs and medications.

PharmaLab 2019 – In times of changes

30 July 2019 | By PharmaLab 2019

For the 7th time, PharmaLab, picks up the latest developments in regulations, quality control and assurance and in laboratory methods and systems.

Roche confirms cyber-attack from Winnti malware

25 July 2019 | By Victoria Rees (European Pharmaceutical Review)

The pharmaceutical company Roche has affirmed that it was hit by a Winnti cyber-attack, thought to be supported by the Chinese government.

Two lots of Kogenate^® recalled due to mislabelling

24 July 2019 | By European Pharmaceutical Review

Two lots of Kogenate® FS vials actually contain the FVIII hemophilia A treatment, Jivi®.